Piper Jaffray Starts Jazz Pharmaceuticals (JAZZ) at Overweight
Tweet
Share
E-mailGet Alerts JAZZ Hot Sheet
Price: $244.96 -0.36%
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Piper Jaffray initiates coverage on Jazz Pharmaceuticals (NASDAQ: JAZZ) with an Overweight. PT $51.
For more ratings news on Jazz Pharmaceuticals click here and for the rating history of Jazz Pharmaceuticals click here.
Shares of Jazz Pharmaceuticals closed at $34.98 yesterday.
For more ratings news on Jazz Pharmaceuticals click here and for the rating history of Jazz Pharmaceuticals click here.
Shares of Jazz Pharmaceuticals closed at $34.98 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- Jazz Pharmaceuticals to acquire Actio Biosciences for $820M upfront
- BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
